GGrantIndex
← Search

ACTG 329: NANDROLONE DECANOATE IN WOMEN WITH HIV WT LOS

$0M01FY2000RRNIH

University Of Pennsylvania, Philadelphia PA

Investigators

Linked publications & trials

Abstract

This is a phase I/II clinical trial, multi-center study to determine the safety and possible effectiveness of a drug called nandrolone decanoate(Deca-Durabolin), which is being tested to treat HIV-associated weight loss. This study will also try to determine if nandrolone treatment can increase your ability to gain lean body weight.

View original record on NIH RePORTER →